These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 27153454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
    Chen H, Zhang X, Zhang X, Fan Z, Liu W, Lei Y, Zhu C, Ma B.
    Bioorg Med Chem; 2020 Oct 15; 28(20):115699. PubMed ID: 33069078
    [Abstract] [Full Text] [Related]

  • 4. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.
    Zou Y, Qin X, Hao X, Zhang W, Yang S, Yang Y, Han Z, Ma B, Zhu C.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3924-7. PubMed ID: 26227780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
    Qin X, Hao X, Han H, Zhu S, Yang Y, Wu B, Hussain S, Parveen S, Jing C, Ma B, Zhu C.
    J Med Chem; 2015 Feb 12; 58(3):1254-67. PubMed ID: 25602762
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.
    Hao X, Han Z, Li Y, Li C, Wang X, Zhang X, Yang Q, Ma B, Zhu C.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):887-892. PubMed ID: 28109789
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
    Huang W, Zhang Y, Liang X, Yang L.
    Arch Pharm (Weinheim); 2020 Jun 15; 353(6):e1900371. PubMed ID: 32237167
    [Abstract] [Full Text] [Related]

  • 19. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
    Shehzad MT, Imran A, Njateng GSS, Hameed A, Islam M, Al-Rashida M, Uroos M, Asari A, Shafiq Z, Iqbal J.
    Bioorg Chem; 2019 Jun 15; 87():857-866. PubMed ID: 30551808
    [Abstract] [Full Text] [Related]

  • 20. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
    Mohd Siddique MU, Thakur A, Shilkar D, Yasmin S, Halakova D, Kovacikova L, Prnova MS, Stefek M, Acevedo O, Dasararaju G, Devadasan V, Mondal SK, Jayaprakash V.
    Eur J Med Chem; 2021 Nov 05; 223():113630. PubMed ID: 34175538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.